We are live on ! Find out more
WST icon

West Pharmaceutical
WST

294 hedge funds and large institutions have $5.45B invested in West Pharmaceutical in 2017 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 114 increasing their positions, 97 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $351K | Put options by funds: $231K

42% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 31

18% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 97

2% more funds holding

Funds holding: 287 → 294 (+7)

0.69% less ownership

Funds ownership: 91.68% → 90.99% (-0.69%)

4% less capital invested

Capital invested by funds: $5.69B → $5.45B (-$244M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
294
Holders Change
+7
Holders Change %
+2.44%
% of All Funds
7.32%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
44
Increased
114
Reduced
97
Closed
31
Calls
$351K
Puts
$231K
Net Calls
+$120K
Net Calls Change
+$2.83M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$480M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$32.8M
3
Wells Fargo
Wells Fargo
California
+$22M
4
Select Equity Group
Select Equity Group
New York
+$16M
5
JP Morgan Chase
JP Morgan Chase
New York
+$15.6M

Top Sellers

Rank Fund Capital Flow
1
KI
Kalmar Investments
Delaware
-$48.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$43.1M
3
GIM
Granahan Investment Management
Massachusetts
-$26.7M
4
RCG
Ruane, Cunniff & Goldfarb
New York
-$26.3M
5
BAMCO Inc
BAMCO Inc
New York
-$19.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Credit Agricole
176
Credit Agricole
France
$734K -$2.52M -30,151 -77%
SAM
177
Silvercrest Asset Management
New York
$732K – – –
MF
178
Magnetar Financial
Illinois
$718K +$736K +8,802 New
QT
179
Quantbot Technologies
New York
$712K +$730K +8,732 New
Russell Investments Group
180
Russell Investments Group
United Kingdom
$687K +$400K +4,789 +133%
V
181
Veritable
Delaware
$591K -$31.9K -381 -5%
FAM
182
Fred Alger Management
New York
$571K -$105K -1,250 -15%
PNC Financial Services Group
183
PNC Financial Services Group
Pennsylvania
$556K +$14.6K +175 +3%
TP
184
Truvvo Partners
New York
$546K -$35.8K -428 -6%
HSBC Holdings
185
HSBC Holdings
United Kingdom
$536K +$12.9K +154 +2%
N
186
Nuveen
North Carolina
$532K -$581K -6,947 -52%
RQS
187
Ramsey Quantitative Systems
Kentucky
$516K +$438K +5,239 New
AG
188
Advisor Group
Arizona
$513K +$19.1K +228 +4%
LPL Financial
189
LPL Financial
California
$495K -$10.7K -128 -2%
Teacher Retirement System of Texas
190
Teacher Retirement System of Texas
Texas
$476K -$5.1K -61 -1%
WA
191
Wheatland Advisors
Pennsylvania
$457K – – –
CANY
192
Caxton Associates (New York)
New York
$457K +$468K +5,600 New
SCM
193
Shelton Capital Management
Colorado
$451K – – –
GHCM
194
Glen Harbor Capital Management
California
$427K +$65.4K +782 +18%
LIA
195
LS Investment Advisors
Michigan
$425K -$8.45K -101 -2%
WAM
196
World Asset Management
Michigan
$421K +$59.8K +715 +16%
HHC
197
Hutchin Hill Capital
New York
$416K -$50.2K -600 -11%
CWA
198
Cypress Wealth Advisors
California
$396K – – –
Verition Fund Management
199
Verition Fund Management
Connecticut
$396K +$406K +4,856 New
BF
200
BOK Financial
Oklahoma
$394K -$1.25K -15 -0.3%
6 7
8
9 10

WST Hedge Fund Activity: Q1 2017 in Review

294 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q1 2017, worth a combined $5.45B — down 4.3% from $5.69B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new WST positions and 31 closed out — a net gain of 13 holders — while 114 added to existing stakes and 97 trimmed.

The largest buyer was BlackRock, adding an estimated $480M. The largest seller was Kalmar Investments, cutting an estimated $48.3M.

  • 294 institutional investors held West Pharmaceutical (WST) as of Q1 2017, up from 287 in Q4 2016.
  • Funds reported $5.45B of West Pharmaceutical stock for Q1 2017, down 4.3% quarter-over-quarter.
  • 44 funds opened new West Pharmaceutical positions in Q1 2017 and 31 closed out, a net change of +13 holders.
  • The largest West Pharmaceutical buyer in Q1 2017 was BlackRock, an estimated $480M added.
  • The largest West Pharmaceutical seller in Q1 2017 was Kalmar Investments, an estimated $48.3M sold.

Based on aggregated 13F filings for Q1 2017.